After completing this activity, pharmacists should be able to:
- To provide an overview of the role of pregabalin in the treatment of neuropathic pain
- To review the characteristics and features of pregabalin, including safety
The 2010 Competency Standards addressed by this activity include: 1.3, 4.2, 6.1, 6.2, 7.2, 7.3
The 2016 Competency Standards addressed by this activity include: 2.1, 3.1, 3.2, 3.5
Accreditation number: A1808RP4 Accreditation expires: 01/09/2020
This activity has been accredited for 0.75 hour of Group One CPD (or 0.75 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 0.75 hour of Group Two CPD (or 1.5 CPD credits) upon successful completion of relevant assessment activity.